Employer profile
Nimbus Therapeutics
2 certified H-1B filings across 1 fiscal year.
FY2024 filings
2
FY2024 median
$215k
Top role
Director, Computational Chemistry
2 filings
Top state
MA
2 filings
Nimbus Therapeutics has filed 2 certified H-1B Labor Condition Applications over FY2024. In FY2024, its median certified base salary was $215k ($215k–$215k interquartile range). The most-filed role is Director, Computational Chemistry (2 filings).
Year-over-year
How Nimbus Therapeutics hired across H-1B fiscal years. YoY column compares to the prior FY.
| FY | Filings | Median $ | YoY % |
|---|---|---|---|
| FY2024 | 2 | $215k | — |
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| Director, Computational Chemistry | 2 | $215k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| MA | 2 | $215k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl IV
2100%
Frequently asked questions
- Does Nimbus Therapeutics sponsor H-1B visas?
- Yes. Nimbus Therapeutics has filed 2 certified H-1B Labor Condition Applications (LCAs) over FY2024. An LCA is a required step before an employer files an H-1B petition; a certified LCA does not by itself guarantee an approved visa.
- What is the median H-1B salary at Nimbus Therapeutics?
- In FY2024, the median certified H-1B base salary at Nimbus Therapeutics was $215k, with a 25th–75th percentile range of $215k–$215k. This is the annual base wage stated on the LCA and excludes bonus, equity, and other compensation.
- What jobs does Nimbus Therapeutics hire H-1B workers for?
- Nimbus Therapeutics's most-filed H-1B role is Director, Computational Chemistry (2 filings). Its top worksite state is MA.
- How many H-1B filings did Nimbus Therapeutics submit in FY2024?
- Nimbus Therapeutics had 2 certified H-1B LCA filings in FY2024.